These findings are expected to provide novel insights into the role of CK18 in linking hepatic injury to cardiovascular dysfunction, thereby informing strategies for early diagnosis and management of cardiovascular complications in NAFLD/MASLD. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.